INNOVATE Act
- Sponsor
- Sen. Ernst, Joni [R-IA]
- Committees
- Small Business and Entrepreneurship Committee (primary)
- Last action
- Jul 23, 2025
Bottom line
This bill seeks to modernize and secure federal small business innovation programs by focusing on national security, broadening participation, and protecting intellectual property from foreign adversaries.
What it actually does
The INNOVATE Act proposes significant reforms to the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. It aims to accelerate the transition of defense technologies, encourage new small business participation through a new 'Phase 1A' program, and implement stringent measures to protect against foreign adversarial influence. The bill also revises commercialization benchmarks for successful firms and streamlines program administration.
Proponents argue
Proponents argue that the bill is essential for strengthening national security by ensuring that federal research and development investments translate into 'battle-ready technologies.' They contend that the measures to combat foreign risk will safeguard American innovation, while new programs for emerging states and rural areas will broaden the base of innovators. Streamlining administrative processes and setting clearer commercialization benchmarks will also improve program efficiency and accountability.
Opponents contend
Critics may contend that the extensive 'foreign risk' provisions could inadvertently stifle legitimate international research collaborations and deter foreign investment in U.S. startups, potentially harming the very innovation ecosystem the bill seeks to protect. Concerns might also be raised about the impact of stricter commercialization benchmarks and funding caps on highly successful, established SBIR/STTR firms, which may be discouraged from pursuing long-term, high-risk R&D. Additionally, the provisions regarding 'discriminatory practices' could be seen as undermining diversity and inclusion efforts within federal programs.
The bill is 19 pages long and contains numerous technical amendments to existing law. An informed reader would require approximately 40 minutes to understand its provisions, which is a reasonable time commitment for a bill of this scope.
Sec. 101
Enhancing Small Business Success in the STTR Program
This section increases the mandatory allocation for the STTR program from 3.2% to 3.45% of an agency's extramural research budget starting in fiscal year 2026. It also adjusts the minimum percentage of work that must be performed by the small business concern and the research institution, shifting the balance to 50% for the small business and 20% for the research institution. Furthermore, it clarifies that the STTR budget for the Department of Defense (DoD) and NASA must solely fund research at Technology Readiness Levels (TRL) 1, 2, and 3, emphasizing early-stage scientific research.
Supporters argue
Proponents argue that increasing the STTR allocation and focusing DoD/NASA STTR funds on early TRLs will stimulate fundamental scientific research, fostering groundbreaking innovations that can later transition into critical technologies. They also believe that giving small businesses a larger share of the work in STTR projects will enhance their capacity and ownership of the developed technology.
Critics contend
No specific opposition is typically raised against increasing STTR allocations or clarifying research focus, as these are generally seen as beneficial for innovation. However, some might argue that a stricter TRL focus could limit flexibility for agencies to support projects that bridge early and mid-stage development.
Tradeoffs
The provision balances the need for increased funding for collaborative research with a clearer focus on early-stage innovation for defense and space agencies. It also adjusts the balance of effort between small businesses and research institutions, potentially shifting more responsibility and benefit to the small business partner.
Sec. 102
Phase II Strategic Breakthrough Funding for DoD
This section establishes a new 'strategic breakthrough allocation' within the Department of Defense's (DoD) SBIR budget, mandating that not less than 0.25% of its extramural research budget be used for this purpose starting in FY2026. This allocation allows DoD to award up to $30 million for a single Phase II project to a small business, significantly higher than typical Phase II awards. Eligibility requires prior Phase II awards, 100% matching funds, and a commitment from a DoD acquisition organization for inclusion in a program objective memorandum, among other criteria. The funds are intended for activities like manufacturing design, facility establishment, raw material purchase, and testing of production units, aiming to accelerate the transition of critical technologies to military use.
Sec. 104
Mandatory Fixed-Price Contracts
This section mandates that all SBIR and STTR funding agreements structured as contracts must be firm-fixed-price contracts. This means the price is set at the outset and does not change, placing the risk of cost overruns on the contractor (the small business). An exception is allowed only if the head of the awarding Federal agency makes a written determination on a case-by-case basis to use a different contract structure.
Sec. 201(a)
SBIR/STTR Funding Cap and PI Limits for Experienced Entrants
This section introduces new restrictions for experienced small businesses and primary investigators (PIs). A small business (including affiliates/spinouts) cannot apply for Phase I or Phase II solicitations if it has previously received over $75 million in cumulative funding from Phase I and Phase II SBIR/STTR awards. Additionally, an individual cannot serve as the primary investigator on more than one proposal to a single Phase I or Phase II solicitation concurrently. It also sets a new Phase I size standard, limiting applicants to those with annual receipts of no more than $40 million for the most recent fiscal year.
Sec. 201(b)
Creation of Phase 1A Program for New Entrants
This section establishes a new 'Phase 1A' program specifically designed to increase accessibility for new small business entrants to the SBIR program. Agencies with an SBIR program are required to allocate at least 2.5% of their SBIR funding to Phase 1A awards. Eligibility is restricted to small businesses that have never received a prior SBIR or STTR award. Proposals are limited to two pages, must be submitted in response to open topic announcements, and awards are capped at $40,000. Recipients of Phase 1A awards are then eligible to apply for a Phase II award.
Sec. 202(7)
Prohibition on Considering Race, Gender, or Ethnicity in Award Decisions
This section establishes new eligibility criteria for agencies to utilize SBIR program funds. Specifically, an agency is ineligible to use these funds if it (A) considers the race, gender, or ethnicity of the principal investigator, founder, or key personnel in an SBIR or STTR award decision; (B) requires or considers a statement or plan to promote diversity or equity as part of an application; or (C) offers supplemental funds based on these characteristics. This effectively prohibits federal agencies from implementing diversity, equity, and inclusion (DEI) considerations in their SBIR/STTR award processes.
Sec. 402
Bolstering Research Security and Expanding Foreign Risk Denials
This section significantly strengthens the evaluation of national security risks for SBIR/STTR awards. It requires agencies to assess whether a small business presents a national security risk through due diligence, disclosures, and coordination with intelligence agencies. Crucially, it expands the conditions for denying an award to include any 'foreign risk' connecting the small business (or its affiliates/personnel) to entities or individuals on specific government watchlists (e.g., UFLPA Entity List, Chinese Military-Industrial Complex Companies List, Entity List). It also prohibits agency personnel from communicating that an application was denied due to foreign risk prior to formal notification.
Sec. 501
Streamlining Transition and Commercialization Rate Benchmarks
This section revises the performance standards for small businesses in the SBIR/STTR programs. For firms receiving more than 10 Phase I awards, a minimum Phase II to Phase I award ratio of 0.25 is established. For those with more than 25 Phase I awards, the ratio increases to 0.5. Failure to meet this higher standard results in a 1-year ban from Phase I, followed by a limit of 5 Phase I awards per year until the standard is met. For firms with more than 25 Phase II awards over their lifetime, new commercialization benchmarks are set: their non-SBIR/STTR annual receipts plus investments must exceed their total Phase I/II awards, and at least 65% of their recent (3-year) receipts/investments must come from non-SBIR/STTR sources. Failure to meet these commercialization standards results in a ban from additional Phase I/II awards until the standard is met.
Sec. 505
Extending SBIR and STTR Authorization
This section extends the authorization for both the SBIR and STTR programs under the Small Business Act. The programs, which were previously authorized through fiscal year 2025, are now extended through fiscal year 2028. This ensures the continued operation and funding of these critical federal programs for small business innovation for an additional three years.
This section makes an agency ineligible to use SBIR program funds if it considers the race, gender, or ethnicity of key personnel in award decisions, requires diversity/equity statements, or offers supplemental funds based on these characteristics.
Sec. 202(7)
Why it matters:This placement could be seen as a strategic legislative practice to embed a potentially contentious policy change within a broader section that has a generally agreeable title. It might also be intended to frame the prohibition on DEI considerations as a measure to combat discrimination itself.
Case for: Proponents argue that this provision ensures that federal funding decisions are based purely on merit and technical excellence, preventing any form of discrimination, including preferential treatment based on demographic characteristics. They believe it promotes a level playing field for all applicants.
Case against: Critics contend that this provision actively undermines efforts to address systemic inequities and increase participation from underrepresented groups in federal R&D. They argue that prohibiting agencies from considering diversity metrics or requiring DEI plans will exacerbate existing disparities and limit the federal government's ability to tap into a broader talent pool.
Estimated impact: This provision would significantly alter how federal agencies approach diversity and inclusion in their SBIR/STTR programs, potentially redirecting or eliminating specific initiatives aimed at minority and women-owned businesses. Its impact would be on the design and implementation of agency outreach and award strategies.
This section significantly expands the conditions and timeframes under which federal agencies can recover SBIR/STTR award amounts (adjusted for inflation). New conditions include the small business selling, leasing, or providing intellectual property (IP) developed with the award to a foreign entity (unless NATO/major non-NATO ally) within 5 years, or to an entity in a foreign country of concern within 10 years. It also allows for 'longer or indefinite' recovery periods if determined necessary for national security.
Sec. 404
Why it matters:The detailed nature of these conditions and the broad grant of authority for indefinite recovery periods are typical of legislative language that grants significant power to agencies. Its placement within a technical amendment section makes it less likely to be highlighted than a new program, despite its substantial implications for small businesses and national security.
Case for: Proponents argue that these expanded recovery authorities are crucial for protecting taxpayer investments and safeguarding sensitive intellectual property developed with federal funds. They contend that the extended timeframes and specific IP transfer conditions are necessary to counter sophisticated foreign adversaries who seek to acquire U.S. technology, ensuring that federal R&D benefits American interests.
Case against: Critics might argue that the 'longer or indefinite period' for recovery, combined with broad IP transfer restrictions, creates significant uncertainty and risk for small businesses. They contend that this could deter legitimate foreign investment and partnerships, which are often essential for commercializing technologies, and could make U.S. startups less attractive to investors due to the potential for federal clawbacks over extended periods.
Estimated impact: This provision significantly increases the financial and legal risk for small businesses receiving SBIR/STTR awards, particularly those with any international dealings or investors. It grants federal agencies substantial power to reclaim funds, potentially impacting investment decisions and the global commercialization strategies of U.S. tech firms.
This section introduces new, stricter commercialization benchmarks for small businesses that have received more than 25 Phase II awards over their lifetime. These firms must demonstrate that the sum of their annual receipts (from non-SBIR/STTR sources) and investments received exceeds the sum of all Phase I and Phase II awards they have ever received. Additionally, at least 65% of their annual receipts and investments over the past three years must come from non-SBIR/STTR sources. Failure to meet these standards results in a ban from applying for additional Phase I or Phase II awards until the benchmark is surpassed.
Sec. 501(2)(B)
Why it matters:The intricate nature of these financial benchmarks is typical of legislative language designed to create precise, data-driven accountability mechanisms. Its placement within a technical section on program administration means it's less likely to be highlighted as a major policy shift, despite its significant implications for highly successful firms.
Case for: Proponents argue that these benchmarks are essential for ensuring that federal R&D investments lead to genuine commercial success and reduce reliance on continuous government funding. They contend that firms with a long history of Phase II awards should demonstrate self-sufficiency and market viability, ensuring that SBIR/STTR funds are not perpetually subsidizing businesses that fail to commercialize.
Case against: Critics might argue that these stringent, retrospective financial benchmarks could unfairly penalize firms that undertake long-term, high-risk R&D projects with delayed commercialization timelines. They contend that such metrics may not fully capture the value of certain innovations, particularly in defense or deep tech, and could force successful firms to exit the program prematurely, losing valuable expertise.
Estimated impact: This provision would significantly impact a subset of highly successful, established small businesses that have historically relied on SBIR/STTR funding for sustained R&D. It could force these firms to dramatically alter their business models, seek alternative funding sources, or potentially exit the federal innovation ecosystem if they cannot meet the new financial thresholds.